In our latest work, we engineered S. boulardii to produce a GLP1R agonist, similar to #ozempic and #wegovy, in the gut. This engineered yeast, showed a remarkable 10% weight reduction in cold exposed mice after 5 days @BackhedLab @ACSSynBio @DTUBiosustain pubs.acs.org/doi/10.1021/ac…
pubs.acs.org Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have... Abstract. Advanced microbiome therapeutics (AMTs) holds promise in utilizing engineered microbes such as bacteria or yeasts for innovative therapeutic appl 
